MedTrace Logo

Theramine® in the Prevention of Migraine Headache

NCT01944059 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-05-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of Theramine® as a preventative for migraine headaches.

Conditions

  • Migraine Headaches

Interventions

DRUG

Theramine (medical food/old drug)

Theramine® is a prescription medical food that is composed of variety of amino acids and/or their precursors.

OTHER

Placebo (l-alanine)

Theramine like placebo comparator

Sponsors & Collaborators

  • Targeted Medical Pharma

    collaborator INDUSTRY

  • Vincent Martin, MD

    lead INDUSTRY

Principal Investigators

  • Vincent Martin, MD · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944059 on ClinicalTrials.gov